Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding notice banner noting potential data delays and that the NIH Clinical Center is open. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check10 days agoChange DetectedThe history page adds a glossary toggle and color-coded change explanations, and removes the No FEAR Act data note while updating the revision to v3.4.0.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision labels in the history were updated with v3.3.4 added and v3.3.3 removed, which are administrative changes to the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link is removed, with Revision: v3.3.2 also deleted.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now shows a new revision tag v3.3.2 in the record, and v3.3.1 is listed as deleted; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed in the page history, reflecting a minor label update in the footer/history section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.